This search looks for keywords in all of the website’s content. Search tips
Filter by
EventHumanAdvanced therapiesResearch and development
HumanAdvanced therapiesRegulatory and procedural guidanceResearch and developmentSME
During the 2020-23 COVID-19 public health emergency, the European Medicines Agency (EMA) provided guidance for medicine developers and pharmaceutical companies to help speed up development and approval for COVID-19 medicines and address regulatory challenges arising from the pandemic.
HumanCOVID-19Clinical trialsCompassionate useRegulatory and procedural guidanceMedicine shortagesResearch and developmentScientific advice
EventHumanAdvanced therapiesResearch and development
EventHumanAdvanced therapiesResearch and development
NewsHumanCOVID-19Research and development
NewsHumanCOVID-19Research and development
NewsHumanCOVID-19Research and developmentVaccines
Press releaseHumanCOVID-19MedicinesResearch and development
Press releaseHumanCOVID-19Clinical trialsQuality of medicinesResearch and developmentVaccines